It was revealed in a recent SEC filing that BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical STAA made a noteworthy insider purchase on December 19,. What Happened: In a recent Form 4 filing ...

On January 17, BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical STAA executed a significant insider buy, as disclosed in the latest SEC filing. What Happened: In a recent Form 4 filing with the ...

Despite the lack of a fourth-quarter pre-announcement, which some investors found puzzling, Stephan sees the potential in Staar Surgical’s long-term growth. The company’s decision to ...

LAKE FOREST, Calif., January 13, 2025--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical (STAA – Research Report) today and set a price target of $39.00. The company’s shares closed yesterday at $23.33.

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for ...